BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38329180)

  • 1. Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315).
    Sebastian M; Eberhardt WEE; von der Heyde E; Dörfel S; Wiegand J; Schiefer C; Losem C; Jänicke M; Fleitz A; Zacharias S; Kaiser-Osterhues A; Hipper A; Dietel C; Bleckmann A; Benkelmann R; Boesche M; Grah C; Müller A; Griesinger F; Thomas M;
    Int J Cancer; 2024 Jun; 154(11):1967-1978. PubMed ID: 38329180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian Perspective.
    Agulnik J; Kasymjanova G; Pepe C; Friedmann J; Small D; Sakr L; Wang H; Spatz A; Sultanem K; Cohen V
    Curr Oncol; 2024 Mar; 31(3):1562-1571. PubMed ID: 38534952
    [No Abstract]   [Full Text] [Related]  

  • 3. KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
    Sebastian M; Eberhardt WEE; Hoffknecht P; Metzenmacher M; Wehler T; Kokowski K; Alt J; Schütte W; Büttner R; Heukamp LC; Stenzinger A; Jänicke M; Fleitz A; Zacharias S; Dille S; Hipper A; Sandberg M; Weichert W; Groschek M; von der Heyde E; Rauh J; Dechow T; Thomas M; Griesinger F;
    Lung Cancer; 2021 Apr; 154():51-61. PubMed ID: 33611226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non-Small-cell Lung Cancer.
    Bordoni R; Ciardiello F; von Pawel J; Cortinovis D; Karagiannis T; Ballinger M; Sandler A; Yu W; He P; Matheny C; Felizzi F; Rittmeyer A
    Clin Lung Cancer; 2018 Sep; 19(5):441-449.e4. PubMed ID: 30017645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology Settings.
    Walker MS; Wong W; Ravelo A; Miller PJE; Schwartzberg LS
    Clin Lung Cancer; 2018 Mar; 19(2):139-147. PubMed ID: 29103883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness outcomes and health related quality of life impact of disease progression in patients with advanced nonsquamous NSCLC treated in real-world community oncology settings: results from a prospective medical record registry study.
    Walker MS; Wong W; Ravelo A; Miller PJE; Schwartzberg LS
    Health Qual Life Outcomes; 2017 Aug; 15(1):160. PubMed ID: 28806963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
    Griesinger F; Eberhardt W; Nusch A; Reiser M; Zahn MO; Maintz C; Bernhardt C; Losem C; Stenzinger A; Heukamp LC; Büttner R; Marschner N; Jänicke M; Fleitz A; Spring L; Sahlmann J; Karatas A; Hipper A; Weichert W; Heilmann M; Sadjadian P; Gleiber W; Grah C; Waller CF; Reck M; Rittmeyer A; Christopoulos P; Sebastian M; Thomas M;
    Lung Cancer; 2021 Feb; 152():174-184. PubMed ID: 33358484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental distress of physicians in the outpatient care throughout the COVID-19 pandemic: emotional and supportive human relations matter - Cross-sectional results of the VOICE-study.
    Mogwitz S; Albus C; Beschoner P; Erim Y; Geiser F; Jerg-Bretzke L; Morawa E; Steudte-Schmiedgen S; Wintermann GB; Weidner K
    BMC Health Serv Res; 2023 May; 23(1):481. PubMed ID: 37173735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Did the Physical and Mental Health of Orthopaedic Patients Change After the Onset of the COVID-19 Pandemic?
    Hollenberg AM; Yanik EL; Hannon CP; Calfee RP; O'Keefe RJ
    Clin Orthop Relat Res; 2023 May; 481(5):935-944. PubMed ID: 36696142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.
    Jarnagin JX; Saraf A; Baiev I; Chi G; van Seventer EE; Mojtahed A; Allen JN; Clark JW; Blaszkowsky L; Giantonio BJ; Weekes CD; Klempner SJ; Franses JW; Roeland EJ; Goyal L; Siravegna G; Horick N; Corcoran RB; Nipp RD; Parikh AR
    JAMA Netw Open; 2023 Nov; 6(11):e2343512. PubMed ID: 37976066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: a real-world evidence survey.
    Bailey H; Lee A; Eccles L; Yuan Y; Burlison H; Forshaw C; Varol N
    BMC Cancer; 2023 Jun; 23(1):603. PubMed ID: 37386452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-Related Quality of Life and Depression Symptoms in a Cross Section of Patients with Advanced Lung Cancer before and during the COVID-19 Pandemic.
    Petrillo LA; El-Jawahri A; Heuer LB; Post K; Gallagher ER; Trotter C; Elyze M; Vyas C; Plotke R; Turk YR; Han J; Temel JS; Greer JA
    J Palliat Med; 2022 Nov; 25(11):1639-1645. PubMed ID: 35588200
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.
    Cameron LB; Hitchen N; Chandran E; Morris T; Manser R; Solomon BJ; Jordan V
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013453. PubMed ID: 34994987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors.
    Bargon CA; Batenburg MCT; van Stam LE; Mink van der Molen DR; van Dam IE; van der Leij F; Baas IO; Ernst MF; Maarse W; Vermulst N; Schoenmaeckers EJP; van Dalen T; Bijlsma RM; Young-Afat DA; Doeksen A; Verkooijen HM
    JNCI Cancer Spectr; 2021 Feb; 5(1):pkaa104. PubMed ID: 33437925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the COVID-19 pandemic on symptoms of anxiety and depression and health-related quality of life in older patients with chronic kidney disease.
    Voorend CGN; van Oevelen M; Nieberg M; Meuleman Y; Franssen CFM; Joosten H; Berkhout-Byrne NC; Abrahams AC; Mooijaart SP; Bos WJW; van Buren M;
    BMC Geriatr; 2021 Nov; 21(1):650. PubMed ID: 34798817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study.
    Waterhouse D; Iadeluca L; Sura S; Wilner K; Emir B; Krulewicz S; Espirito J; Bartolome L
    Target Oncol; 2022 Jan; 17(1):25-33. PubMed ID: 34964940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: A single-center, observational study.
    Vlake JH; Wesselius S; van Genderen ME; van Bommel J; Boxma-de Klerk B; Wils EJ
    PLoS One; 2021; 16(8):e0255774. PubMed ID: 34379644
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.